SuperworthVanda Pharmaceuticals shares outstanding VNDA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 60.2M
- On a year earlier
- +2.1%
- more shares
Vanda Pharmaceuticals had 60.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 59.1M | +1% |
| FY2024 | 58.3M | +1% |
| FY2023 | 57.5M | +1% |
| FY2022 | 57.2M | −0% |
| FY2021 | 57.2M | +3% |
| FY2020 | 55.6M | +1% |
| FY2019 | 55M | −0% |
| FY2018 | 55.2M | +23% |
| FY2017 | 44.9M | +2% |
| FY2016 | 44M | +3% |
| FY2015 | 42.8M | +8% |
| FY2014 | 39.5M | +19% |
| FY2013 | 33.3M | +18% |
| FY2012 | 28.2M | +0% |
| FY2011 | 28.1M | −3% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 60.2M | +2% | |
| Q1 FY26 | 59.5M | +2% | |
| Q4 FY25 | 59.1M | +1% | |
| Q3 FY25 | 59.1M | +1% | |
| Q2 FY25 | 59M | +1% | |
| Q1 FY25 | 58.5M | +1% | |
| Q4 FY24 | 58.3M | +1% | |
| Q3 FY24 | 58.3M | +1% | |
| Q2 FY24 | 58.2M | +1% | |
| Q1 FY24 | 57.8M | +1% | |
| Q4 FY23 | 57.5M | +1% | |
| Q3 FY23 | 57.6M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Vanda Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.